SKYRIZI 150 MG/ML SOL INJ CT BL X SER PREENC VD TRANS + CAN APLIC X 1 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1986000160040 -
GGREM
543724110005607 -
Código de barras
8054083021317
O que a fonte publica
- Detentor do registro
- ABBVIE FARMACÊUTICA LTDA.
- Princípios ativos
- RISANQUIZUMABE
- Embalagem
- 150 MG/ML SOL INJ CT BL X SER PREENC VD TRANS + CAN APLIC X 1 ML
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L4C - INIBIDORES DA INTERLEUCINA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "SKYRIZI 150 MG/ML SOL INJ CT BL X SER PREENC VD TRANS + CAN APLIC X 1 ML",
"holder": "ABBVIE FARMACÊUTICA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"8054083021317"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "543724110005607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "15.800.545/0001-50",
"priceRegime": "Regulado",
"productName": "SKYRIZI",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "150 MG/ML SOL INJ CT BL X SER PREENC VD TRANS + CAN APLIC X 1 ML",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "18792.75",
"icms-12": "21355.40",
"icms-17": "22641.86",
"icms-18": "22917.98",
"icms-19": "23200.93",
"icms-20": "23490.94",
"icms-21": "23788.30",
"icms-22": "24093.26",
"icms-23": "24406.16",
"icms-17.5": "22779.09",
"icms-19.5": "23345.03",
"icms-20.5": "23638.69",
"icms-22.5": "24248.72",
"icms-12-alc": "19067.33",
"icms-17-alc": "20215.94",
"icms-18-alc": "20462.49",
"icms-19-alc": "20715.10",
"icms-20-alc": "20974.04",
"icms-21-alc": "21239.55",
"icms-22-alc": "21511.84",
"icms-23-alc": "21791.21",
"withoutTaxes": "16779.24",
"icms-17.5-alc": "20338.47",
"icms-19.5-alc": "20843.77",
"icms-20.5-alc": "21105.95",
"icms-22.5-alc": "21650.62"
},
"pisCofinsList": "Negativa",
"substanceText": "RISANQUIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "25209.81",
"icms-12": "28647.51",
"icms-17": "30373.25",
"icms-18": "30743.65",
"icms-19": "31123.22",
"icms-20": "31512.26",
"icms-21": "31911.16",
"icms-22": "32320.25",
"icms-23": "32739.99",
"icms-17.5": "30557.34",
"icms-19.5": "31316.53",
"icms-20.5": "31710.46",
"icms-22.5": "32528.79",
"icms-12-alc": "26359.47",
"icms-17-alc": "27947.35",
"icms-18-alc": "28288.19",
"icms-19-alc": "28637.41",
"icms-20-alc": "28995.38",
"icms-21-alc": "29362.43",
"icms-22-alc": "29738.86",
"icms-23-alc": "30125.07",
"withoutTaxes": "23196.31",
"icms-17.5-alc": "28116.74",
"icms-19.5-alc": "28815.29",
"icms-20.5-alc": "29177.74",
"icms-22.5-alc": "29930.71"
},
"invalidBarcodes": [],
"activeSubstances": [
"RISANQUIZUMABE"
],
"therapeuticClass": "L4C - INIBIDORES DA INTERLEUCINA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1986000160040",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L4C",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:543724110005607"